-
AASLD China Spotlight丨Dr. Xin Zheng and Dr. Jia Liu’s Team Unveils Early Immunological Mechanisms in TMF Treatment for Chronic Hepatitis B
Key Findings from the Study The research, conducted by a team including Dr. Jia Liu, Dr. Shue Xiong, Dr. Hang Jia, and Master’s student Xufeng Quan, involved 37 treatment-naïve CHB…
-
ASH 2024 | Dr. Ruidong Zhang and Dr. Peijing Qi: Analysis of Blinatumomab’s Efficacy and Prospects in Pediatric B-ALL
The 66th Annual Meeting of the American Society of Hematology (ASH) was held from December 7 to 10, 2024, in San Diego, USA. This global event brought together leading experts in hematology to discuss the latest advancements in the field. At the meeting, the team led by Dr. Ruidong Zhang from Beijing Children’s Hospital，Capital Medical…
-
ASH 2024丨Dr. Qingxiao Song’s Team Wins Two ASH Abstract Achievement Awards, Explores New Mechanisms and Therapies for cGVHD
The 66th American Society of Hematology (ASH) Annual Meeting, held in San Diego from December 7–10, 2024, brought together global hematology experts to discuss the latest research advancements. Among the noteworthy contributions, Dr. Qingxiao Song’s team from the Hematology Medical Center of The Second Affiliated Hospital of Army Medical University (Xinqiao Hospital) had three studies…
-
Dr. Bing Xu and Dr. Zhijuan Lin’s Team: Highlighting the Role of the Immune Microenvironment and the Promise of Bispecific Antibodies for FL Patients
The 66th American Society of Hematology (ASH) Annual Meeting concluded successfully from December 7 to 10, 2024, in San Diego, USA. As the largest and most comprehensive international academic conference in the field of hematology, ASH attracts numerous experts and scholars worldwide to discuss groundbreaking research and advancements in hematology.At this year’s ASH meeting, the…
-
ASH 2024 | Dr. Fengkui Zhang: How to Treat Severe Aplastic Anemia in Patients Unable to Undergo Transplantation? Promising Results with a New TPO-RA Combined with IST
The 66th Annual Meeting of the American Society of Hematology (ASH) was held from December 7–10, 2024, in San Diego, USA. As the largest international academic conference in hematology, it showcased cutting-edge research and the latest advancements in drug development, representing the highest level of academic achievement in the field. Severe aplastic anemia (SAA) remains…
-
ASH 2024 | Dr. Xiaowen Tang’s Team Pioneers Innovative Transplant Pathways: From Enhanced Preconditioning Strategies to Multi-Targeted CAR-T Sequential Transplantation
The 66th Annual Meeting of the American Society of Hematology (ASH), held from December 7–10, 2024, in San Diego, USA, brought together global hematology experts to discuss the latest advancements in the field. Among the highlights of this year’s conference were seven groundbreaking studies from Dr. Xiaowen Tang’s team at The First Affiliated Hospital of…
-
ASH 2024 | Dr. Ying Wang: Sustained Remission and Safety – Promising Prospects of CD19 CAR-T Therapy for R/R B-ALL
The 66th Annual Meeting of the American Society of Hematology (ASH), held from December 7–10, 2024, in San Diego, USA, brought together global hematology experts to discuss the latest advancements in the field. Among the highlights was a poster presentation (P4196) by Dr. Ying Wang from the Institute of Hematology and Blood Diseases Hospital, Chinese…
-
Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment
At the conference, Dr. Jiajie Liao from Zhongshan Hospital, led a research team that presented a study evaluating the impact of various antiviral treatment strategies on achieving functional cure for…
Connecting Medical Expertise through Media